Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis.
about
Systematic review and network meta-analysis comparing palbociclib with chemotherapy agents for the treatment of postmenopausal women with HR-positive and HER2-negative advanced/metastatic breast cancerPractical consensus recommendations regarding the use of hormonal therapy in metastatic breast cancer.Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis.
P2860
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Comparison of palbociclib in c ...... cancer: network meta-analysis.
@en
Comparison of palbociclib in c ...... cancer: network meta-analysis.
@nl
type
label
Comparison of palbociclib in c ...... cancer: network meta-analysis.
@en
Comparison of palbociclib in c ...... cancer: network meta-analysis.
@nl
prefLabel
Comparison of palbociclib in c ...... cancer: network meta-analysis.
@en
Comparison of palbociclib in c ...... cancer: network meta-analysis.
@nl
P2093
P2860
P1476
Comparison of palbociclib in c ...... cancer: network meta-analysis.
@en
P2093
Ann Colosia
Caroline Ling
Costel Chirila
Debanjali Mitra
James A Kaye
Shrividya Iyer
P2860
P304
P356
10.1080/03007995.2017.1325730
P407
P577
2017-05-02T00:00:00Z